SYNLOGIC, INC. Accumulated Other Comprehensive Income
SYNLOGIC, INC. (SYBX) had Accumulated Other Comprehensive Income of $0 as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-05-14
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $6.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $5.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$30.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$161.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | -$391.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$433.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$345.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$45.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $9.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $11.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $5.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $14.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $79.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $214.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $55.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $110.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $114.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $68.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $39.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$65.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$47.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$75.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$111.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$9.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$2.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$117.15M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | -$107.77M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$102.79M 10-Q · filed 2017-08-04 | -$4.00K 10-K · filed 2017-03-15 |
| 2016-09-30 | -$8.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $6.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $9.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |